Background We performed a comprehensive assessment of the psychometrics of the Psychosocial Aspects in Hereditary Cancer (PAHC) questionnaire in French, German and Spanish. Methods Women consecutively approached in Cancer Genetic Clinics completed the PAHC, distress and satisfaction questionnaires at pre-testing (T1) and after test result disclosure (T2). In addition to standard psychometric attributes, we assessed the PAHC ability to respond to change (i.e. improvement or deterioration from T1 to T2) in perceived difficulties and computed minimal important differences (MID) in PAHC scores as compared with self-reported needs for additional counselling. Results Of 738 eligible counselees, 214 (90%) in France (Paris), 301 (92%) in Germany (C...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
Background We performed a comprehensive assessment of the psychometrics of the "Psychosocial Aspects...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
Altres ajuts: Ile-de-France Cancer Pole: 2015-1-EMERG-14-ICH-1; SiRIC label Institut CurieObjectives...
Objectives and setting Advances in multigene panel testing for cancer susceptibility has increased t...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
Background We performed a comprehensive assessment of the psychometrics of the "Psychosocial Aspects...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
International audienceBackgroundTo design appropriate cancer genetic services for women at high brea...
Altres ajuts: Ile-de-France Cancer Pole: 2015-1-EMERG-14-ICH-1; SiRIC label Institut CurieObjectives...
Objectives and setting Advances in multigene panel testing for cancer susceptibility has increased t...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...
International audienceObjectives and setting Advances in multigene panel testing for cancer suscepti...